• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AUTOGEN; CARDIAC DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AUTOGEN; CARDIAC DEFIBRILLATOR Back to Search Results
Model Number G173
Device Problem High impedance (1291)
Patient Problems No Known Impact Or Consequence To Patient (2692); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/01/2019
Event Type  malfunction  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) system exhibited out of range pacing impedance measurements in both the right atrial (ra) and right ventricular (rv) leads.The rv lead is a non-boston scientific device.The patients is in permanent atrial fibrillation (af).Boston scientific technical services (ts) reviewed the stored data and recommended actively monitoring the patient.The system remains in service.No adverse patient effects were reported.
 
Manufacturer Narrative
This product has not been returned to boston scientific, and as a result, laboratory analysis could not be conducted.However, the associated investigation determined that this device exhibited intermittent impedance measurements with no conclusive evidence of a malfunction or inadequate lead-to-device connection; please refer to the description for more information regarding the specific circumstances of this event.Investigation has determined that this type of event is likely the result of an intermittent high impedance condition associated with the device spring contact and lead terminal ring.A design enhancement was implemented in 2020 to stabilize the electrical connection between the spring contact and the lead terminal.If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) system exhibited out of range (oor) pacing impedance measurements in both the right atrial (ra) and right ventricular (rv) leads.Both leads are non-boston scientific devices.The patient is in permanent atrial fibrillation (af).Boston scientific technical services (ts) reviewed the stored data and recommended actively monitoring the patient.The system remains in service.No adverse patient effects were reported.Additional information stated the patient is under active remote monitoring.No in-person checks have been performed so far.However, the clinic programmed alerts for non-physiological rv noise and rv oor pacing impedance.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AUTOGEN
Type of Device
CARDIAC DEFIBRILLATOR
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key11212085
MDR Text Key228162919
Report Number2124215-2021-01428
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 04/16/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date12/11/2018
Device Model NumberG173
Device Catalogue NumberG173
Device Lot Number119381
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/22/2020
Initial Date FDA Received01/22/2021
Supplement Dates Manufacturer Received02/11/2021
Supplement Dates FDA Received04/16/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-